Form 4 for TLSI TriSalus Life Sciences, Inc.
Accepted 2024-12-19 00:00:00 ET · period of report 2024-12-17 · accession 0001415889-24-029904 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-19 | 2024-12-17 | TLSI | Frankenius Equity AB | 10% | P - Purchase | $3.97 | +63.0K | 6.23M | +1% | +$250.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-17 | P | A | 62,972 | $3.97 | 6,230,748 | D | — | — | (F1) The shares were issued in connection with the closing of the transaction contemplated by the Securities Purchase Agreement, entered into December 12, 2024, by and between the Issuer and Reporting Person. |